Analysis of cerebral infarction caused by dysplasminogenemia in three pedigrees

Dysplasminogenemia is a rare heritable disease caused by plasminogen (PLG) gene defects resulting in hypercoagulability. In this report we describe three notable cases of cerebral infarction (CI) complicated with dysplasminogenemia in young patients. Coagulation indices were examined on STAGO STA-R-...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in genetics 2023-03, Vol.14, p.1132654-1132654
Main Authors: Chen, Xuanyu, Zou, Ming, Lu, Chunxing, Zhou, Ruyi, Lou, Shuyue, Wang, Yujia, Ding, Hongxiang, Han, Zhao, Hu, Beilei
Format: Article
Language:English
Subjects:
dysplasminogenemia
genetic mutations
Genetics
heredity
juvenile stroke
plasminogen
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dysplasminogenemia is a rare heritable disease caused by plasminogen (PLG) gene defects resulting in hypercoagulability. In this report we describe three notable cases of cerebral infarction (CI) complicated with dysplasminogenemia in young patients. Coagulation indices were examined on STAGO STA-R-MAX analyzer. PLG: A was analyzed using a chromogenic substrate-based approach using a chromogenic substrate method. All nineteen exons of PLG gene and their 5'and 3'flanking regions were amplified by Polymerase chain reaction (PCR). Suspected mutation was confirmed by reverse sequencing. PLG activity (PLG:A) in proband 1 and 3 of his tested family members, proband 2 and 2 of his tested family members, and proband 3 and her father were all reduced to roughly 50% of normal levels. Sequencing led to the identification of a heterozygous c.1858G>A missense mutation in exon 15 of the PLG gene in these three patients and affected family members. We conclude that the observed reduction in PLG:A was the result of this .Ala620Thr missense mutation in the PLG gene. The CI incidence in these probands may be attributable to the inhibition of normal fibrinolytic activity as a consequence of this heterozygous mutation.
ISSN:1664-8021
1664-8021
DOI:10.3389/fgene.2023.1132654